TipRanks
Advertisement
Advertisement

KRYS Stock Latest News

Krystal Biotech price target raised to $416 from $386 at Citi
The FlyKrystal Biotech price target raised to $416 from $386 at Citi
6d ago
KRYS
Krystal Biotech advances KB113 for Gorlin syndrome
PremiumCompany Announcements
Krystal Biotech advances KB113 for Gorlin syndrome
6d ago
8K
KRYS
Krystal Biotech provides clinical data for KB113 program
PremiumThe Fly
Krystal Biotech provides clinical data for KB113 program
6d ago
KRYS
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
PremiumTipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) Enters Study Start-Up Agreement for Lucid-MS Phase 2 Trial
15d ago
BBIO
KRYS
Krystal Biotech resumed with a Buy at Goldman Sachs
PremiumThe Fly
Krystal Biotech resumed with a Buy at Goldman Sachs
27d ago
KRYS
Krystal Biotech price target raised to $400 from $392 at BofA
PremiumThe FlyKrystal Biotech price target raised to $400 from $392 at BofA
1M ago
KRYS
Krystal Biotech initiated with an Outperform at RBC Capital
Premium
The Fly
Krystal Biotech initiated with an Outperform at RBC Capital
2M ago
KRYS
Micron upgraded, Cisco downgraded: Wall Street’s top analyst calls
Premium
The Fly
Micron upgraded, Cisco downgraded: Wall Street’s top analyst calls
2M ago
W
MU
Krystal Biotech Earnings Call Signals Profitable Growth
PremiumCompany Announcements
Krystal Biotech Earnings Call Signals Profitable Growth
3M ago
KRYS
Alec Stranahan Maintains Buy on Krystal Biotech, Slightly Lowers Price Target to $392 Amid Strong Vyjuvek Momentum and Pipeline Catalysts
PremiumRatings
Alec Stranahan Maintains Buy on Krystal Biotech, Slightly Lowers Price Target to $392 Amid Strong Vyjuvek Momentum and Pipeline Catalysts
3M ago
KRYS
Krystal Biotech price target lowered to $392 from $396 at BofA
PremiumThe Fly
Krystal Biotech price target lowered to $392 from $396 at BofA
3M ago
KRYS
Krystal Biotech price target raised to $386 from $378 at Citi
PremiumThe Fly
Krystal Biotech price target raised to $386 from $378 at Citi
3M ago
KRYS
Analyst Backs Krystal with Buy Rating on Vyjuvek Launch Momentum and Rare-Disease Pipeline Upside
PremiumRatingsAnalyst Backs Krystal with Buy Rating on Vyjuvek Launch Momentum and Rare-Disease Pipeline Upside
3M ago
KRYS
Morning Movers: Supernus and Indivior jump following merger pact
Premium
The Fly
Morning Movers: Supernus and Indivior jump following merger pact
3M ago
AZN
BMY
Krystal Biotech reports Q2 EPS $1.79, consensus $1.91
Premium
The Fly
Krystal Biotech reports Q2 EPS $1.79, consensus $1.91
3M ago
KRYS
KRYS Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
KRYS Upcoming Earnings Report: What to Expect?
3M ago
KRYS
Krystal Biotech Updates KB801 Patent Office Filing
PremiumCompany Announcements
Krystal Biotech Updates KB801 Patent Office Filing
3M ago
8K
KRYS
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
PremiumThe Fly
Krystal Biotech to replace Taylor Morrison in S&P 400 at open on 7/24
3M ago
KRYS
TMHC
Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
PremiumThe Fly
Tutor Perini to replace Krystal Biotech in S&P 600 at open on 7/24
3M ago
TPC
KRYS
Krystal Biotech price target raised to $396 from $364 at BofA
PremiumThe FlyKrystal Biotech price target raised to $396 from $364 at BofA
3M ago
KRYS
Krystal Biotech price target raised to $474 from $399 at Jefferies
Premium
The Fly
Krystal Biotech price target raised to $474 from $399 at Jefferies
3M ago
KRYS
Krystal Biotech price target raised to $403 from $306 at TD Cowen
Premium
The Fly
Krystal Biotech price target raised to $403 from $306 at TD Cowen
4M ago
KRYS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >